Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Simcere Grants Almirall Global Rights to Autoimmune Drug SIM0278

February 4, 2025
CompanyDeals

Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion

February 4, 2025
Company

Santen Pharmaceutical Launches New Plant Construction in Suzhou

February 5, 2025
CompanyDrug

Legend Biotech’s Carvykti Approved in Japan for Relapsed Multiple Myeloma

February 4, 2025
CompanyDeals

Eureka Biotech Partners with Ucello for Universal CAR-T Cell Therapy Development

February 4, 2025
CompanyDeals

Merck Sharp & Dohme Partners with Sinopharm for Molnupiravir in China

February 4, 2025
CompanyDrug

NMPA Releases 59th Batch of Reference Drugs for Generic Quality Evaluation

February 4, 2025
Company

SciClone Pharmaceuticals Reports 10.8% Revenue Growth in 2022 Interim Results

February 4, 2025
CompanyDrug

Harbour BioMed Doses First Subject in Phase I Study for HBM9378 in China

February 4, 2025
CompanyMedical Device

MicroPort CardioFlow’s Alwide Plus Balloon Catheter Approved in Colombia

February 4, 2025
CompanyDeals

Zai Lab Licenses Seagen’s Tivdak for Greater China Development and Commercialization

February 4, 2025
CompanyDrug

Telix Pharmaceuticals Gains IND Approval for TLX250-CDx in China

February 4, 2025
1 2 3 4 5 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up